ReviewMolecular cancer2024

Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the "all-around warrior" in immunotherapy.

Qiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.